Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yanan Zhu's Stock Ratings
Wells Fargo Analyst
Yanan Zhu is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
1.06%
Smart Score
Overall Average Return Percentile
37th
Number of Ratings
120
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/12/2025 | QURE | Buy Now | uniQure | $23.00 | 160.87% | $80 → $60 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 31.18% | $17 → $12 | Maintains | Equal-Weight | Get Alert | |
| 11/05/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 109.9% | $50 → $45 | Maintains | Overweight | Get Alert | |
| 11/03/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 139.92% | $48 → $72 | Maintains | Overweight | Get Alert | |
| 10/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 85.83% | $45 → $17 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/23/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 181.29% | $42 → $20 | Maintains | Overweight | Get Alert | |
| 10/21/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 59.95% | $38 → $48 | Maintains | Overweight | Get Alert | |
| 10/02/2025 | QURE | Buy Now | uniQure | $23.00 | 247.83% | $65 → $80 | Maintains | Overweight | Get Alert | |
| 09/25/2025 | QURE | Buy Now | uniQure | $23.00 | 182.61% | $30 → $65 | Maintains | Overweight | Get Alert | |
| 09/03/2025 | EDIT | Buy Now | Editas Medicine | $2.49 | 60.7% | $3 → $4 | Maintains | Equal-Weight | Get Alert | |
| 08/25/2025 | NAMS | Buy Now | NewAmsterdam Pharma Co | $35.35 | 27.3% | → $45 | Initiates | → Overweight | Get Alert | |
| 08/22/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | 2.81% | $77 → $82 | Maintains | Overweight | Get Alert | |
| 08/14/2025 | MGX | Buy Now | Metagenomi | $1.82 | 559.34% | $16 → $12 | Maintains | Overweight | Get Alert | |
| 08/13/2025 | TSHA | Buy Now | Taysha Gene Therapies | $5.75 | 39.13% | $7.5 → $8 | Maintains | Overweight | Get Alert | |
| 08/13/2025 | FATE | Buy Now | Fate Therapeutics | $1.10 | 127.27% | $4 → $2.5 | Maintains | Equal-Weight | Get Alert | |
| 08/13/2025 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 201.2% | $6 → $5 | Maintains | Overweight | Get Alert | |
| 08/12/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 490.72% | $45 → $42 | Maintains | Overweight | Get Alert | |
| 08/08/2025 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 26.62% | $51 → $38 | Maintains | Overweight | Get Alert | |
| 08/08/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 548.15% | $18 → $14 | Maintains | Overweight | Get Alert | |
| 08/08/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 391.91% | $50 → $45 | Maintains | Overweight | Get Alert | |
| 08/08/2025 | RNA | Buy Now | Avidity Biosciences | $71.86 | 4.37% | $70 → $75 | Maintains | Overweight | Get Alert | |
| 08/07/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 133.23% | $48 → $50 | Maintains | Overweight | Get Alert | |
| 07/24/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 123.9% | $65 → $48 | Maintains | Overweight | Get Alert | |
| 07/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 203.19% | $75 → $65 | Maintains | Overweight | Get Alert | |
| 06/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 249.84% | $100 → $75 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | MGX | Buy Now | Metagenomi | $1.82 | 779.12% | $20 → $16 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 532.91% | $50 → $45 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $1.5 → $1 | Maintains | Equal-Weight | Get Alert | |
| 05/13/2025 | AFMD | Buy Now | Affimed | — | — | $11 → $0.1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/08/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 366.45% | $115 → $100 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 160.13% | $75 → $70 | Maintains | Overweight | Get Alert | |
| 05/01/2025 | RGLS | Buy Now | Regulus Therapeutics | — | — | → $9 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 04/11/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.44 | 436.42% | → $115 | Initiates | → Overweight | Get Alert | |
| 03/27/2025 | RGLS | Buy Now | Regulus Therapeutics | — | — | $3 → $6 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/21/2025 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $2 → $1.5 | Maintains | Equal-Weight | Get Alert | |
| 03/21/2025 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 261.45% | $8 → $6 | Maintains | Overweight | Get Alert | |
| 03/18/2025 | MGX | Buy Now | Metagenomi | $1.82 | 998.9% | $25 → $20 | Maintains | Overweight | Get Alert | |
| 03/12/2025 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 133.64% | $12 → $10 | Maintains | Overweight | Get Alert | |
| 03/07/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 603.23% | $58 → $50 | Maintains | Overweight | Get Alert | |
| 03/06/2025 | FATE | Buy Now | Fate Therapeutics | $1.10 | 263.64% | $5 → $4 | Maintains | Equal-Weight | Get Alert | |
| 02/28/2025 | QURE | Buy Now | uniQure | $23.00 | 30.43% | $35 → $30 | Maintains | Equal-Weight | Get Alert | |
| 02/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 446.57% | $60 → $50 | Maintains | Overweight | Get Alert | |
| 02/24/2025 | BLUE | Buy Now | bluebird bio | — | — | $40 → $5 | Maintains | Equal-Weight | Get Alert | |
| 01/10/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 555.88% | $70 → $60 | Maintains | Overweight | Get Alert | |
| 12/12/2024 | AFMD | Buy Now | Affimed | — | — | $20 → $15 | Maintains | Overweight | Get Alert | |
| 12/11/2024 | EDIT | Buy Now | Editas Medicine | $2.49 | 60.7% | $7 → $4 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 11/18/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 665.19% | $80 → $70 | Maintains | Overweight | Get Alert | |
| 11/12/2024 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | -86.67% | $17 → $4 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -3.46% | $82 → $77 | Maintains | Overweight | Get Alert | |
| 11/05/2024 | EDIT | Buy Now | Editas Medicine | $2.49 | 181.23% | $9 → $7 | Maintains | Overweight | Get Alert | |
| 10/23/2024 | EDIT | Buy Now | Editas Medicine | $2.49 | 261.58% | $27 → $9 | Maintains | Overweight | Get Alert | |
| 09/25/2024 | BLUE | Buy Now | bluebird bio | — | — | $3 → $2 | Maintains | Equal-Weight | Get Alert | |
| 05/13/2024 | SYRE | Buy Now | Spyre Therapeutics | $33.34 | 19.98% | $35 → $40 | Maintains | Overweight | Get Alert | |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $56.00 | 16.07% | $70 → $65 | Maintains | Equal-Weight | Get Alert | |
| 05/08/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | 2.81% | $85 → $82 | Maintains | Overweight | Get Alert | |
| 04/22/2024 | ENGN | Buy Now | enGene Holdings | $8.43 | 255.87% | → $30 | Initiates | → Overweight | Get Alert | |
| 04/01/2024 | AFMD | Buy Now | Affimed | — | — | $30 → $25 | Maintains | Overweight | Get Alert | |
| 03/27/2024 | BLUE | Buy Now | bluebird bio | — | — | $4 → $3 | Maintains | Equal-Weight | Get Alert | |
| 03/08/2024 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 715.75% | $45 → $58 | Maintains | Overweight | Get Alert | |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $1.82 | 1273.63% | → $25 | Initiates | → Overweight | Get Alert | |
| 03/01/2024 | SYRE | Buy Now | Spyre Therapeutics | $33.34 | 4.98% | $12 → $35 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/01/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1057.41% | $22 → $25 | Maintains | Overweight | Get Alert | |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 918.52% | $17 → $22 | Maintains | Overweight | Get Alert | |
| 01/03/2024 | RNA | Buy Now | Avidity Biosciences | $71.86 | -30.42% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert | |
| 01/02/2024 | VYGR | Buy Now | Voyager Therapeutics | $4.28 | 227.1% | $9 → $14 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 12/27/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $10 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/15/2023 | BLUE | Buy Now | bluebird bio | — | — | $8 → $5 | Maintains | Equal-Weight | Get Alert | |
| 11/14/2023 | AFMD | Buy Now | Affimed | — | — | $4 → $3 | Maintains | Overweight | Get Alert | |
| 11/09/2023 | FATE | Buy Now | Fate Therapeutics | $1.10 | 354.55% | $6 → $5 | Maintains | Equal-Weight | Get Alert | |
| 08/16/2023 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | $0.35 → $0.5 | Maintains | Equal-Weight | Get Alert | |
| 08/11/2023 | AFMD | Buy Now | Affimed | — | — | $5 → $4 | Maintains | Overweight | Get Alert | |
| 08/10/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.44 | 799.08% | $5 → $4 | Maintains | Overweight | Get Alert | |
| 07/13/2023 | AVRO | Buy Now | Avrobio | — | — | $2.5 → $2 | Maintains | Overweight | Get Alert | |
| 05/30/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 687.04% | $11 → $17 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/25/2023 | AFMD | Buy Now | Affimed | — | — | $7 → $5 | Maintains | Overweight | Get Alert | |
| 05/11/2023 | RNA | Buy Now | Avidity Biosciences | $71.86 | -30.42% | $55 → $50 | Maintains | Overweight | Get Alert | |
| 05/05/2023 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 261.45% | $8 → $6 | Maintains | Overweight | Get Alert | |
| 03/27/2023 | AFMD | Buy Now | Affimed | — | — | → $7 | Assumes | → Overweight | Get Alert | |
| 03/27/2023 | TCRT | Buy Now | Alaunos Therapeutics | $4.25 | -29.45% | → $3 | Assumes | → Overweight | Get Alert | |
| 03/27/2023 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 381.93% | → $8 | Assumes | → Overweight | Get Alert | |
| 03/27/2023 | FATE | Buy Now | Fate Therapeutics | $1.10 | 445.45% | → $6 | Assumes | → Equal-Weight | Get Alert | |
| 03/27/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $7 | Assumes | → Overweight | Get Alert | |
| 03/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 409.26% | → $11 | Assumes | → Equal-Weight | Get Alert | |
| 03/01/2023 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 290.19% | $125 → $105 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.75 | 73.91% | $14 → $10 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.44 | 3271.54% | $20 → $15 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 59.95% | $55 → $48 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 1211.76% | $135 → $120 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | EDIT | Buy Now | Editas Medicine | $2.49 | 1346.31% | $50 → $36 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | RNA | Buy Now | Avidity Biosciences | $71.86 | -23.46% | $60 → $55 | Maintains | Overweight | Get Alert | |
| 11/14/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $1.5 → $3 | Maintains | Equal-Weight | Get Alert | |
| 11/07/2022 | SGMO | Buy Now | Sangamo Therapeutics | $0.44 | 4395.39% | $22 → $20 | Maintains | Overweight | Get Alert | |
| 10/28/2022 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | $1.5 → $2 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/25/2022 | AGTC | Buy Now | Applied Genetic Techs | — | — | $0.5 → $0.4 | Maintains | Equal-Weight | Get Alert | |
| 10/04/2022 | AGTC | Buy Now | Applied Genetic | — | — | $12 → $0.5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/10/2022 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 1278.34% | $105 → $98 | Maintains | Overweight | Get Alert | |
| 08/09/2022 | QURE | Buy Now | uniQure | $23.00 | 4.35% | $34 → $24 | Maintains | Equal-Weight | Get Alert | |
| 08/09/2022 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | $2 → $1.5 | Maintains | Equal-Weight | Get Alert | |
| 03/25/2022 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 1376.79% | $107 → $105 | Maintains | Overweight | Get Alert | |
| 03/11/2022 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 83.27% | $65 → $55 | Maintains | Overweight | Get Alert | |
| 03/08/2022 | BLUE | Buy Now | bluebird bio | — | — | $12 → $8 | Maintains | Equal-Weight | Get Alert | |
| 03/01/2022 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 1404.92% | $118 → $107 | Maintains | Overweight | Get Alert | |
| 03/01/2022 | TSHA | Buy Now | Taysha Gene Therapies | $5.75 | 334.78% | → $25 | Initiates | → Overweight | Get Alert | |
| 08/10/2021 | BLUE | Buy Now | bluebird bio | — | — | $60 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/16/2021 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 438.83% | → $145 | Initiates | → Overweight | Get Alert | |
| 02/02/2021 | ARGX | Buy Now | argenx | $844.00 | -61.37% | $272 → $326 | Maintains | Equal-Weight | Get Alert | |
| 01/07/2021 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | — | — | Initiates | → Overweight | Get Alert | |
| 12/10/2020 | EDIT | Buy Now | Editas Medicine | $2.49 | 2672.09% | $28 → $69 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/29/2020 | CCXI | Buy Now | ChemoCentryx | — | — | $79 → $70 | Maintains | Overweight | Get Alert | |
| 08/19/2020 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $48 → $52.5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/27/2020 | CCXI | Buy Now | ChemoCentryx | — | — | → $79 | Initiates | → Overweight | Get Alert | |
| 05/07/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | $122 → $133 | Maintains | Overweight | Get Alert | |
| 02/21/2020 | EDIT | Buy Now | Editas Medicine | $2.49 | 1024.9% | → $28 | Initiates | → Equal-Weight | Get Alert | |
| 12/09/2019 | BLUE | Buy Now | bluebird bio | — | — | $242 → $160 | Maintains | Overweight | Get Alert | |
| 11/25/2019 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 9.96% | → $33 | Initiates | → Outperform | Get Alert | |
| 11/06/2019 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | — | Initiates | → Outperform | Get Alert | |
| 10/09/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | $96 → $104 | Maintains | Outperform | Get Alert | |
| 04/01/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | $85 → $96 | Maintains | Outperform | Get Alert | |
| 09/30/2016 | GBT | Buy Now | Global Blood Therapeutics | — | — | — | Initiates | → Outperform | Get Alert | |
| 12/04/2015 | BLUE | Buy Now | bluebird bio | — | — | — | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved